Utah Medical Products, Inc.
UTMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $13,874 | $16,635 | $16,473 | $14,788 |
| Dep. & Amort. | $2,846 | $6,368 | $7,082 | $7,284 |
| Deferred Tax | $0 | -$681 | -$401 | -$92 |
| Stock-Based Comp. | $256 | $225 | $183 | $166 |
| Change in WC | -$1,803 | -$233 | -$2,226 | -$1,006 |
| Other Non-Cash | -$342 | -$33 | $36 | $63 |
| Operating Cash Flow | $14,831 | $22,281 | $21,147 | $21,203 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$235 | -$639 | -$818 | -$552 |
| Net Acquisitions | $27 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$208 | -$639 | -$818 | -$552 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $117 | $0 | $560 |
| Stock Repurch. | -$19,968 | -$2,495 | -$2,495 | -$6,976 |
| Dividends Paid | -$4,260 | -$4,282 | -$3,163 | -$11,465 |
| Other Fin. Act. | $390 | $0 | $174 | $0 |
| Financing Cash Flow | -$23,838 | -$4,165 | -$5,484 | -$10,905 |
| Forex Effect | -$677 | $339 | -$767 | -$362 |
| Net Chg. in Cash | -$9,892 | $17,816 | $14,078 | $9,384 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $92,868 | $75,052 | $60,974 | $51,590 |
| End Cash | $82,976 | $92,868 | $75,052 | $60,974 |
| Free Cash Flow | $14,596 | $21,642 | $20,329 | $20,651 |